Murat Croci | Ibex Biosciences – Translating Breakthrough Science into Clinical-Stage Therapies

In this episode of Executive Insights for Life Sciences Innovators, we speak with Murat Croci, Co-CEO of Ibex Biosciences, a biotechnology company developing novel therapies to address major unmet medical needs in oncology and infectious disease.Murat discusses how Ibex is advancing high-conviction therapeutic programs from preclinical success toward the clinic, and the discipline required to translate strong scientific data into IND-ready assets. He shares insights from his career across biotechnology, operations, and company leadership, and how taking personal capital risk alongside investors shapes his approach to execution and decision-making.We explore the realities of early-stage drug development, balancing portfolio focus with optionality, and the challenges founders face as programs transition from discovery into clinical development. Murat also offers his perspective on leadership under risk and what it takes to build durable biotech companies in today’s funding environment.This episode was streamed live on YouTube on February 6, 2026. Learn more at ⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠.